MANKIND.NS
MANKIND.NS
INE634S01028
MANKIND PHARMA LIMITED
Loading chart...

Company Profile

-

Related stocks

ZYDUSLIFE.NS
ZYDUSLIFE.NS • India
ZYDUS LIFESCIENCES LTD
1,117.5 INR
11.52B USD 1Y +12.8%
LAURUSLABS.NS
LAURUSLABS.NS • India
LAURUS LABS LIMITED
2,036.6 INR
11.37B USD 1Y +135.4%
RDY
RDY • India
Dr. Reddy's Laboratories Ltd
12.48 USD
10.4B USD 1Y -12.8%
DRREDDY.NS
DRREDDY.NS • India
DR. REDDY S LABORATORIES
1,197 INR
10.3B USD 1Y -3.9%
LUPIN.NS
LUPIN.NS • India
LUPIN LIMITED
1,956.5 INR
9.24B USD 1Y -0.1%
CIPLA.NS
CIPLA.NS • India
CIPLA LTD
1,301 INR
10.86B USD 1Y -14%
AUROPHARMA.NS
AUROPHARMA.NS • India
AUROBINDO PHARMA LTD
1,693 INR
10.07B USD 1Y +51.2%
ALKEM.NS
ALKEM.NS • India
ALKEM LABORATORIES LTD.
5,279 INR
6.52B USD 1Y -4.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
India
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
29.9% p.a.
Max Drawdown (3Y)
-35.7%
Sharpe Ratio (3Y)
0.27
Beta Factor
0.45
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 50.3 (Elevated multiple compression risk)
ende